SEEL - Seelos Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

SEEL is currently covered by 3 analysts with an average price target of $-2.92. This is a potential upside of $-3.22 (-1073.33%) from yesterday's end of day stock price of $0.3.

Seelos Therapeutics's activity chart (see below) currently has 5 price targets and 14 ratings on display. The stock rating distribution of SEEL is 80% BUY and 20% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 340.5 days.

Highest price target for SEEL is $4, Lowest price target is $4, average price target is $-2.92.

Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 21-Sep-2023.

Best performing analysts who are covering SEEL - Seelos Therapeutics:

Mayank Mamtani Jonathan Aschoff Bruce Jackson Charles Duncan Robert Hazlett Yatin Suneja

Currently out of the existing stock ratings of SEEL, 4 are a BUY (80%), 1 are a HOLD (20%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

2

7 months 5 days ago

4/4 (100%)

$0.89 (80.18%)

140

Buy

4

$2.93 (273.83%)

7 months 5 days ago

2/2 (100%)

$-1.7 (-29.82%)

117

Buy

4

$3.8 (1900.00%)

14

11 months 11 days ago

0/3 (0%)

$8.04 (318.77%)

Buy

6

$4.93 (460.75%)

11

2 years 1 months 12 days ago

3/3 (100%)

$-19.65 (-76.61%)

641

Buy

2 years 6 months 25 days ago

2/2 (100%)

$-6.91 (-36.54%)

1145

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SEEL (Seelos Therapeutics) average time for price targets to be met?

On average it took 340.5 days on average for the stock forecasts to be realized with a an average price target met ratio 66.67

Which analyst has the current highest performing score on SEEL (Seelos Therapeutics) with a proven track record?

MAYANK MAMTANI

Which analyst has the current lower performing score on SEEL (Seelos Therapeutics) with a proven track record?

YATIN SUNEJA

Which analyst has the most public recommendations on SEEL (Seelos Therapeutics)?

Mayank Mamtani works at B. RILEY and has 3 price targets and 2 ratings on SEEL

Which analyst is the currently most bullish on SEEL (Seelos Therapeutics)?

Mayank Mamtani with highest potential upside - $4.93

Which analyst is the currently most reserved on SEEL (Seelos Therapeutics)?

Jonathan Aschoff with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?